An interactive web-based programme on relapse management for people with multiple sclerosis (POWER@MS2) - development, feasibility, and pilot testing of a complex intervention

INTRODUCTION: Despite the lack of high-quality evidence regarding its long-term effectiveness, intravenous corticosteroid therapy is recommended as the standard treatment of acute multiple sclerosis relapses in Germany. High financial expenses and the equivalent effectiveness of oral corticosteroid...

Descripción completa

Detalles Bibliográficos
Autores principales: Wenzel, Lisa, Heesen, Christoph, Peper, Julia, Grentzenberg, Kristina, Faßhauer, Edeltraud, Scheiderbauer, Jutta, Thale, Frithjof, Meyer, Björn, Köpke, Sascha, Rahn, Anne Christin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538652/
https://www.ncbi.nlm.nih.gov/pubmed/36212638
http://dx.doi.org/10.3389/fneur.2022.914814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538652/
https://www.ncbi.nlm.nih.gov/pubmed/36212638
http://dx.doi.org/10.3389/fneur.2022.914814

Ejemplares similares